» Articles » PMID: 21273306

E47 Regulates Hematopoietic Stem Cell Proliferation and Energetics but Not Myeloid Lineage Restriction

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2011 Jan 29
PMID 21273306
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The immune system is replenished by self-renewing hematopoietic stem cells (HSCs) that produce multipotent progenitors (MPPs) with little renewal capacity. E-proteins, the widely expressed basic helix-loop-helix transcription factors, contribute to HSC and MPP activity, but their specific functions remain undefined. Using quantitative in vivo and in vitro approaches, we show that E47 is dispensable for the short-term myeloid differentiation of HSCs but regulates their long-term capabilities. E47-deficient progenitors show competent myeloid production in short-term assays in vitro and in vivo. However, long-term myeloid and lymphoid differentiation is compromised because of a progressive loss of HSC self-renewal that is associated with diminished p21 expression and hyperproliferation. The activity of E47 is shown to be cell-intrinsic. Moreover, E47-deficient HSCs and MPPs have altered expression of genes associated with cellular energy metabolism, and the size of the MPP pool but not downstream lymphoid precursors in bone marrow or thymus is rescued in vivo by antioxidant. Together, these observations suggest a role for E47 in the tight control of HSC proliferation and energy metabolism, and demonstrate that E47 is not required for short-term myeloid differentiation.

Citing Articles

Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.

Parriott G, Hegermiller E, Morman R, Frank C, Saygin C, Stock W Leukemia. 2023; 38(3):491-501.

PMID: 38155245 DOI: 10.1038/s41375-023-02123-4.


Inhibitor of DNA binding proteins revealed as orchestrators of steady state, stress and malignant hematopoiesis.

Singh S, Sarkar T, Jakubison B, Gadomski S, Spradlin A, Gudmundsson K Front Immunol. 2022; 13:934624.

PMID: 35990659 PMC: 9389078. DOI: 10.3389/fimmu.2022.934624.


Hematopoietic Stem Cells and Regeneration.

Biermann M, Reya T Cold Spring Harb Perspect Biol. 2021; 14(8).

PMID: 34750175 PMC: 9341464. DOI: 10.1101/cshperspect.a040774.


Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

Steinauer N, Guo C, Huang C, Wong M, Tu Y, Freter C Blood Adv. 2019; 3(9):1379-1393.

PMID: 31040112 PMC: 6517668. DOI: 10.1182/bloodadvances.2018028514.


The Concerted Action of E2-2 and HEB Is Critical for Early Lymphoid Specification.

Bouderlique T, Pena-Perez L, Kharazi S, Hils M, Li X, Krstic A Front Immunol. 2019; 10:455.

PMID: 30936870 PMC: 6433000. DOI: 10.3389/fimmu.2019.00455.


References
1.
Purton L, Scadden D . Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell. 2008; 1(3):263-70. DOI: 10.1016/j.stem.2007.08.016. View

2.
Lyons-Weiler J, Patel S, Becich M, Godfrey T . Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics. 2004; 5:110. PMC: 514539. DOI: 10.1186/1471-2105-5-110. View

3.
Borghesi L, Aites J, Nelson S, Lefterov P, James P, Gerstein R . E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J Exp Med. 2005; 202(12):1669-77. PMC: 2212960. DOI: 10.1084/jem.20051190. View

4.
Morrison S, Wandycz A, Akashi K, Globerson A, Weissman I . The aging of hematopoietic stem cells. Nat Med. 1996; 2(9):1011-6. DOI: 10.1038/nm0996-1011. View

5.
Cellot S, Krosl J, Chagraoui J, Meloche S, Humphries R, Sauvageau G . Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Exp Hematol. 2007; 35(5):802-16. PMC: 2752385. DOI: 10.1016/j.exphem.2007.02.013. View